SCHEMBL26145362

SCHEMBL26145362

COc1c(Cl)cc(C)c2cc[nH]c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO2 P16083 3/20 0.40
▸ CYP19A1 P11511 2/20 0.40
▸ MAPT P10636 1/20 0.36
▸ CHUK O15111 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.35
▸ AXL P30530 1/20 0.34
▸ PRKCI P41743 1/20 0.34
▸ DBH P09172 1/20 0.34
▸ BRD4 O60885 3/20 0.33
▸ TAS1R3 Q7RTX0 1/20 0.33
▸ TAS1R1 Q7RTX1 1/20 0.33
▸ TAS1R2 Q8TE23 1/20 0.33
▸ NR3C1 P04150 1/20 0.33
▸ PGR P06401 1/20 0.33
▸ ACHE P22303 2/20 0.33
▸ HTR4 Q13639 2/20 0.33
▸ SIGMAR1 Q99720 2/20 0.33
▸ TUBB4A P04350 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19420465 0.83 ACHE (0.39) NQO2CYP19A1CHUKKDM4EALDH1A1
SCHEMBL24787445 0.81 CSNK2A1 (0.39) CHUKKDM4EALDH1A1DBHBRD4
SCHEMBL26145361 0.79 NQO2 (0.40) NQO2CYP19A1KDM4EALDH1A1RXFP1
SCHEMBL21725760 0.79 ACHE (0.35) CHUKKDM4EALDH1A1DBHACHE
SCHEMBL21726012 0.79 THRB (0.35) CHUKKDM4EALDH1A1DBHBRD4
SCHEMBL20939366 0.74 P2RX7 (0.42) MAPTAXLPRKCINR3C1PGR
SCHEMBL20577299 0.72 EGFR (0.34) DBHNR3C1PGRACHEHTR4
SCHEMBL25647648 0.71 NQO2 (0.42) NQO2CYP19A1MAPTKDM4EALDH1A1
SCHEMBL5997719 0.71 CHUK (0.38) NQO2CYP19A1CHUKKDM4EALDH1A1
SCHEMBL19418758 0.71 ACHE (0.39) NQO2CHUKKDM4EALDH1A1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151002-A1 6-5 FUSED RINGS AS C5a INHIBITORS CHEMOCENTRYX, INC. 2023-05-18 — — US disclosed
US-20230151002-A1 6-5 FUSED RINGS AS C5a INHIBITORS CHEMOCENTRYX, INC. 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151002-A1 6-5 FUSED RINGS AS C5a INHIBITORS C5AR1, C5AR2, C3AR1 NQO2 2552/4885CYP19A1 2658/4885MAPT 4546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback